Our Story
Aparito was founded by Dr. Elin Haf Davies in 2014 to empower patients in the drug development pathway and transform how clinical studies are conducted and novel eCOAs are developed.
Initially designed for rare diseases, Aparito’s Atom5™ eCOA platform allows studies to be carried out anytime, anywhere, enabling patients and their caregivers to participate in research at the clinic and home.
Project Workflow
Engage / Operationalize
Atom5™
Full stack eCOA platform that is ISO 13485 / IEC 27001:2016 accredited and FDA 21 CFR Part 11, HIPAA and GDPR compliant
Complete Data Capture
Collect patient data at home and in the clinic using video assessments, wearables and PROs
Real-Time Analysis
Real time patient data 24/7/365 at individual and cohort level for analysis and publication